J. Goldman & Co’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Hold
0
685
2025
Q4
Sell
-8,401
Closed -$1.17M 586
2025
Q3
$1.02M Sell
8,401
-31,254
-79% -$3.52M 0.04% 328
2025
Q2
$4.14M Buy
39,655
+37,359
+1,627% +$3.96M 0.13% 217
2025
Q1
$268K Sell
2,296
-38,027
-94% -$4.33M 0.01% 425
2024
Q4
$3.41M Buy
40,323
+32,044
+387% +$2.95M 0.12% 226
2024
Q3
$744K Sell
8,279
-57
-0.7% -$4.97K 0.03% 317
2024
Q2
$671K Sell
8,336
-560
-6% -$41.5K 0.02% 342
2024
Q1
$710K Buy
8,896
+3,341
+60% +$280K 0.03% 298
2023
Q4
$442K Sell
5,555
-48,256
-90% -$3.23M 0.02% 272
2023
Q3
$3.76M Buy
53,811
+37,865
+237% +$2.83M 0.19% 153
2023
Q2
$1.15M Sell
15,946
-46,405
-74% -$3.42M 0.07% 243
2023
Q1
$3.85M Buy
62,351
+59,652
+2,210% +$3.92M 0.22% 165
2022
Q4
$208K Buy
+2,699
New +$161K 0.01% 312
2020
Q1
Sell
-3,753
Closed -$388K 251
2019
Q4
$388K Sell
3,753
-7,624
-67% -$308K 0.04% 227
2019
Q3
$230K Buy
11,377
+1,699
+18% +$43.7K 0.03% 259
2019
Q2
$249K Sell
9,678
-37,295
-79% -$748K 0.03% 244
2019
Q1
$668K Buy
+46,973
New +$436K 0.06% 220

Other funds holding AXSM